Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with Ropivacaine for PECS Block in Cardiac Surgery
NCT05897307Unknown
- Sponsor
- Fayoum University Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Fayoum University Hospital. Primary endpoint: Total Postoperative Opioid Consumption at 48 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05897307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897307.